|
ZA836080B
(en)
*
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
WO1996033735A1
(en)
|
1995-04-27 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
WO1994016109A1
(en)
*
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
*
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
*
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
JP2003528571A
(ja)
|
1999-04-29 |
2003-09-30 |
シンジェンタ リミテッド |
除草剤抵抗性植物
|
|
PL355287A1
(en)
*
|
1999-09-24 |
2004-04-05 |
Smithkline Beecham Biologicals S.A. |
Intranasal influenza virus vaccine
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
ES2319864T3
(es)
*
|
2000-04-28 |
2009-05-14 |
St. Jude Children's Research Hospital |
Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa.
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
KR101113432B1
(ko)
|
2002-02-13 |
2012-02-29 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
WO2004067553A2
(en)
|
2003-01-29 |
2004-08-12 |
The Research Foundation Of The State University Of New York |
Tolerance-induced targeted antibody production
|
|
CA2514667C
(en)
*
|
2003-01-30 |
2013-01-08 |
Chiron Corporation |
Adjuvanted influenza vaccine
|
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
KR20060035596A
(ko)
|
2003-05-05 |
2006-04-26 |
보이스 톰슨 인스터튜트 포 플랜트 리서치 |
외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
ES2372633T3
(es)
*
|
2003-11-04 |
2012-01-25 |
The Administrators Of The Tulane Educational Fund |
Procedimiento de evitar condensación de virus: células inhibiendo la función de la región de iniciación de condensación en los virus arn que tienen proteínas de envoltura fusogénicas de membrana de clase i.
|
|
JP4980895B2
(ja)
*
|
2004-05-25 |
2012-07-18 |
メディミューン，エルエルシー |
インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
|
|
US8420102B2
(en)
|
2006-03-07 |
2013-04-16 |
Vaxinnate Corporation |
Compositions that include hemagglutinin
|
|
US7566454B2
(en)
*
|
2005-02-24 |
2009-07-28 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
|
EP1885186B1
(en)
|
2005-06-01 |
2015-09-02 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
NZ568211A
(en)
*
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
PL2251034T3
(pl)
|
2005-12-02 |
2018-07-31 |
Icahn School Of Medicine At Mount Sinai |
Chimeryczne wirusy prezentujące nienatywne białka powierzchniowe i zastosowania tych wirusów
|
|
PT1968632E
(pt)
*
|
2005-12-06 |
2012-07-16 |
Yeda Res & Dev |
Vacina da gripe melhorada
|
|
US10183986B2
(en)
*
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
WO2007134327A2
(en)
|
2006-05-15 |
2007-11-22 |
Sea Lane Biotechnologies, Llc. |
Neutralizing antibodies to influenza viruses
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
WO2008054540A2
(en)
*
|
2006-05-18 |
2008-05-08 |
Pharmexa Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
US20100143406A1
(en)
|
2006-06-30 |
2010-06-10 |
Gale Smith |
Methods of enhancing protein incorporation into virus like particles
|
|
US8329162B2
(en)
|
2006-07-21 |
2012-12-11 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
EP2450377A1
(en)
|
2006-09-07 |
2012-05-09 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
|
EP4585610A3
(en)
|
2006-09-11 |
2025-09-24 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
|
WO2008154813A1
(fr)
*
|
2007-06-15 |
2008-12-24 |
Xiamen University |
Anticorps monoclonaux se liant à l'hémagglutinine du virus de la grippe aviaire du sous type h5 et ses utilisations
|
|
EP2014279A1
(en)
*
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
WO2009076778A1
(en)
|
2007-11-27 |
2009-06-25 |
Medicago Inc. |
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
|
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
|
US9421254B2
(en)
*
|
2007-09-24 |
2016-08-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunostimulatory combinations of TLR ligands and methods of use
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
RU2010127156A
(ru)
|
2007-12-06 |
2012-01-20 |
Дана-Фарбер Кэнсер Инститьют, Инк. (Us) |
Антитела против вируса гриппа и их применение
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
JP2011516423A
(ja)
|
2008-03-28 |
2011-05-26 |
シー レーン バイオテクノロジーズ， エルエルシー |
ウイルス抗原に対する中和分子
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
WO2010003766A2
(en)
*
|
2008-06-17 |
2010-01-14 |
Apogenix Gmbh |
Multimeric tnf receptors
|
|
BRPI0914691A2
(pt)
|
2008-06-25 |
2015-10-20 |
Inserm Inst Nat De La Santé Et De La Rech Médicale |
composto imunoadjuvante, composição, uso de um composto imunoadjuvante, ácido nucléico, vetor recombinante, e, célula hospedeira
|
|
AU2009267769B2
(en)
|
2008-07-08 |
2015-07-16 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
WO2010117786A1
(en)
|
2009-03-30 |
2010-10-14 |
Mount Sinai School Of Medicine Of New York University |
Influenza virus vaccines and uses thereof
|
|
CA2761648C
(en)
|
2009-05-11 |
2019-03-12 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
US8673314B2
(en)
*
|
2009-05-26 |
2014-03-18 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
HUE039100T2
(hu)
|
2009-06-24 |
2018-12-28 |
Medicago Inc |
Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék
|
|
US8828406B2
(en)
*
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
*
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
EP2536425B1
(en)
|
2010-02-18 |
2019-06-19 |
Icahn School of Medicine at Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
EP3098236A1
(en)
|
2010-03-08 |
2016-11-30 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
CN102939103A
(zh)
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
|
WO2012009790A1
(en)
|
2010-07-22 |
2012-01-26 |
Schrader John W |
Cross-protective pathogen protection, methods and compositions thereof
|
|
EP4241785B1
(en)
|
2011-09-20 |
2026-01-28 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
EP3566714A1
(en)
|
2011-11-28 |
2019-11-13 |
Janssen Vaccines & Prevention B.V. |
Influenza virus vaccines and uses thereof
|
|
EP2931747B1
(en)
|
2012-12-11 |
2020-06-10 |
Vib Vzw |
Anti-influenza antibody
|
|
SG11201504728RA
(en)
|
2012-12-18 |
2015-07-30 |
Icahn School Med Mount Sinai |
Influenza virus vaccines and uses thereof
|